Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 2 |
2021 | 2 |
2022 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Uterine lavage identifies cancer mutations and increased TP53 somatic mutation burden in individuals with ovarian cancer.
Cancer Res Commun. 2022 Oct;2(10):1282-1292. doi: 10.1158/2767-9764.crc-22-0314. Epub 2022 Oct 27.
Cancer Res Commun. 2022.
PMID: 36311816
Free PMC article.
Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations.
Ghezelayagh TS, Pennington KP, Norquist BM, Khasnavis N, Radke MR, Kilgore MR, Garcia RL, Lee M, Katz R, Leslie KK, Risques RA, Swisher EM.
Ghezelayagh TS, et al.
Gynecol Oncol. 2021 Mar;160(3):786-792. doi: 10.1016/j.ygyno.2020.12.007. Epub 2020 Dec 26.
Gynecol Oncol. 2021.
PMID: 33375991
Free PMC article.
Item in Clipboard
Colorectal Cancer Is Associated with the Presence of Cancer Driver Mutations in Normal Colon.
Matas J, Kohrn B, Fredrickson J, Carter K, Yu M, Wang T, Gui X, Soussi T, Moreno V, Grady WM, Peinado MA, Risques RA.
Matas J, et al.
Cancer Res. 2022 Apr 15;82(8):1492-1502. doi: 10.1158/0008-5472.CAN-21-3607.
Cancer Res. 2022.
PMID: 35425963
Free PMC article.
Item in Clipboard
PolyG-DS: An ultrasensitive polyguanine tract-profiling method to detect clonal expansions and trace cell lineage.
Zhang Y, Kohrn BF, Yang M, Nachmanson D, Soong TR, Lee IH, Tao Y, Clevers H, Swisher EM, Brentnall TA, Loeb LA, Kennedy SR, Salk JJ, Naxerova K, Risques RA.
Zhang Y, et al.
Proc Natl Acad Sci U S A. 2021 Aug 3;118(31):e2023373118. doi: 10.1073/pnas.2023373118.
Proc Natl Acad Sci U S A. 2021.
PMID: 34330826
Free PMC article.
Item in Clipboard
Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma.
Krimmel-Morrison JD, Ghezelayagh TS, Lian S, Zhang Y, Fredrickson J, Nachmanson D, Baker KT, Radke MR, Hun E, Norquist BM, Emond MJ, Swisher EM, Risques RA.
Krimmel-Morrison JD, et al.
Gynecol Oncol. 2020 Feb;156(2):407-414. doi: 10.1016/j.ygyno.2019.11.124. Epub 2019 Dec 12.
Gynecol Oncol. 2020.
PMID: 31839337
Free PMC article.
Item in Clipboard
TP53 somatic evolution in cervical liquid-based cytology and blood from individuals with and without ovarian cancer and BRCA1 or BRCA2 germline mutations.
Ghezelayagh TS, Kohrn BF, Fredrickson J, Krimmel-Morrison JD, Latorre-Esteves E, Tee XR, Radke MR, Manhardt E, Norquist BM, Katz R, Swisher EM, Risques RA.
Ghezelayagh TS, et al.
Oncogene. 2024 Jul;43(31):2421-2430. doi: 10.1038/s41388-024-03089-y. Epub 2024 Jun 25.
Oncogene. 2024.
PMID: 38918516
Item in Clipboard
Cite
Cite